GE Healthcare acquired the license to a new molecular imaging agent that could be useful in diagnosing heart attacks and monitoring how well tumors respond to drugs, the company reports. Get an early glimpse of the promising project.
A less invasive method of breast biopsy appears to be nearly as effective as open surgical ones to determine if a growth in the breast is cancerous, according to a report issued this month by a government-convened panel.
Twelve years after the FDA first got involved in PET drugs, they've at last released final rules controlling their manufacture -- rules which could place a burden on smaller drug producers, according to an industry group.
Working with scientists at the National Institutes of Health, Philips Research has come up with an experimental "cockpit" they hope will help doctors perform liver-tumor radiofrequency ablations more accurately, so they can tackle larger tumors.
Scientists and CEOs advise the Canadian government on options to make up for the expected medical isotope shortage as the aging National Research Universal reactor, Canada's isotope-producing workhorse, nears the end of the road.
Last week at RSNA 2009, our camera crew caught up with Donald Barry, Ph.D., product general manager for X-ray of ContextVision, to talk about the latest products for lowering radiation exposure from imaging studies.
An ultrasound technique that measures stiffness of tissue dramatically improves detection rates in finding breast cancer, according to a presentation at the annual meeting of the Radiological Society of North America (RSNA).
Many patients going in for an abdominal CT scan get additional series largely intended only for patients with kidney problems, according to a study presented at the Radiological Society of North American (RSNA).